BOLA3缺陷调控肺动脉高压内皮代谢与甘氨酸稳态
该研究探讨BOLA3在肺动脉高压(PH)中的作用机制。在体外低氧内皮细胞、PH患者肺组织及多种啮齿类PH模型中,内皮BOLA3表达下调,且由HIF-2α依赖的转录抑制介导。BOLA3缺失通过影响Fe-S完整性及甘氨酸裂解系统蛋白H,促进内皮增殖、生存和血管收缩,在 mice 中敲低内皮BOLA3可加重PH表型,而过表达BOLA3的治疗效应可被外源性甘氨酸补充逆转。
要点
- PH内皮中BOLA3表达下调,受HIF-2α/HDAC1轴转录抑制。
- BOLA3缺失破坏Fe-S完整性,调控糖酵解和线粒体呼吸。
- BOLA3缺失升高内皮甘氨酸水平,促进增殖、生存和血管收缩。
核心结论
- BOLA3是连接Fe-S依赖性氧化呼吸与甘氨酸稳态的关键节点,参与PH内皮代谢重编程。
研究设计与样本
- 体外使用siRNA和慢病毒载体在人肺动脉内皮细胞中进行BOLA3功能获得和缺失实验。
- 小鼠中采用聚合物纳米颗粒7C1递送BOLA3 siRNA至肺内皮,或用腺相关病毒经气管转基因过表达肺血管BOLA3。
主要发现
- 低氧肺动脉内皮细胞、Group 1和3 PH患者肺组织及多种啮齿类PH模型中内皮BOLA3表达下调。
- BOLA3调控Fe-S完整性,影响含硫辛酸的2-氧酸脱氢酶,从而控制糖酵解和线粒体呼吸。
- BOLA3缺失下调甘氨酸裂解系统蛋白H,增加细胞内甘氨酸含量。
- BOLA3缺失增加内皮增殖、生存和血管收缩,降低血管生成潜能。
- 小鼠内皮BOLA3敲低促进PH的组织学和血流动力学表现,BOLA3过表达的治疗效应被外源性甘氨酸补充逆转。
临床怎么用
- BOLA3及其调控的Fe-S生物合成和甘氨酸代谢通路可作为PH诊断和治疗开发的新靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Deficiencies of iron-sulfur (Fe-S) clusters, metal complexes that control redox state and mitochondrial metabolism, have been linked to pulmonary hypertension (PH), a deadly vascular disease with poorly defined molecular origins. BOLA3 (BolA Family Member 3) regulates Fe-S biogenesis, and mutations in BOLA3 result in multiple mitochondrial dysfunction syndrome, a fatal disorder associated with PH. The mechanistic role of BOLA3 in PH remains undefined. METHODS: In vitro assessment of BOLA3 regulation and gain- and loss-of-function assays were performed in human pulmonary artery endothelial cells using siRNA and lentiviral vectors expressing the mitochondrial isoform of BOLA3. Polymeric nanoparticle 7C1 was used for lung endothelium-specific delivery of BOLA3 siRNA oligonucleotides in mice. Overexpression of pulmonary vascular BOLA3 was performed by orotracheal transgene delivery of adeno-associated virus in mouse models of PH. RESULTS: In cultured hypoxic pulmonary artery endothelial cells, lung from human patients with Group 1 and 3 PH, and multiple rodent models of PH, endothelial BOLA3 expression was downregulated, which involved hypoxia inducible factor-2α-dependent transcriptional repression via histone deacetylase 1-mediated histone deacetylation. In vitro gain- and loss-of-function studies demonstrated that BOLA3 regulated Fe-S integrity, thus modulating lipoate-containing 2-oxoacid dehydrogenases with consequent control over glycolysis and mitochondrial respiration. In contexts of siRNA knockdown and naturally occurring human genetic mutation, cellular BOLA3 deficiency downregulated the glycine cleavage system protein H, thus bolstering intracellular glycine content. In the setting of these alterations of oxidative metabolism and glycine levels, BOLA3 deficiency increased endothelial proliferation, survival, and vasoconstriction while decreasing angiogenic potential. In vivo, pharmacological knockdown of endothelial BOLA3 and targeted overexpression of BOLA3 in mice demonstrated that BOLA3 deficiency promotes histological and hemodynamic manifestations of PH. Notably, the therapeutic effects of BOLA3 expression were reversed by exogenous glycine supplementation. CONCLUSIONS: BOLA3 acts as a crucial lynchpin connecting Fe-S-dependent oxidative respiration and glycine homeostasis with endothelial metabolic reprogramming critical to PH pathogenesis. These results provide a molecular explanation for the clinical associations linking PH with hyperglycinemic syndromes and mitochondrial disorders. These findings also identify novel metabolic targets, including those involved in epigenetics, Fe-S biogenesis, and glycine biology, for diagnostic and therapeutic development.
引用
- Yu Q, Tai YY, Tang Y, et al. BOLA (BolA Family Member 3) Deficiency Controls Endothelial Metabolism and Glycine Homeostasis in Pulmonary Hypertension. Circulation. 2019. PMID: 30759996. doi:10.1161/CIRCULATIONAHA.118.035889
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。